Cyclobenzaprine Hydrochloride Tablets USP 10 mg
Product details
- Cyclobenzaprine Hydrochloride Tablets USP 10 mg
Company announcement
Unichem Pharmaceuticals is recalling Cyclobenzaprine Hydrochloride Tablets because the label was inadvertently placed on a bottle containing Meloxicam tablets.
The product was distributed nationwide.
No adverse events have been reported to date.
Risk:
For patients who unknowingly take Meloxicam there is a reasonable probability of serious adverse events including cardiovascular, gastrointestinal, renal, anaphylaxis, and skin reactions, particularly in those patients taking concomitant non-steroidal anti-Inflammatory drugs and/or blood thinners, those who have allergies to the Meloxicam, or those with underlying illness.
Impacted states: Nationwide
Products:
- Cyclobenzaprine Hydrochloride Tablets USP 10 mg
Contact
For more information, email rxrecalls@inmar.com.